Skip to content
Home/Companies/MedTech/Abanza Tecnomed
Abanza Tecnomed

Abanza Tecnomed

MedTech·Spain·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Abanza Tecnomed?

Abanza Tecnomed was owned by Clave Mayor through UN I+D+i Technology Transfer FCR (2015 vintage) from 2018 to 2025, exited via Secondary.

Hand-verified · updated 2026-08-09

Clave Mayor
Investor
Clave Mayor
UN I+D+i Technology Transfer FCR · 2015 · VC

Key facts

HQSpain
SectorMedTech
StatusAcquired
Websitewww.abanzamed.com
Exit Type
Secondary
Buyer
–
MOIC
Exit Year
2025

More from UN I+D+i Technology Transfer FCR

Other portfolio companies in the same fund.

Polimerbio
Polimerbio
Active
MedTechSpain· 2020
Nucaps
Nucaps
Active
BiotechSpain· 2017
Innoprick
Active
MedTechSpain· 2016

More Clave Mayor portfolio companies

From the same investor, across funds.

ADmit Therapeutics
Active
BiotechSpain· 2023
Nanological
Nanological
Active
BiotechSpain· 2023
Agro Singularity
Active
AgTechSpain· 2021
Corify Care
Active
MedTechSpain· 2021
Heura
Heura
Active
FoodTechSpain· 2021
Moa Foodtech
Active
FoodTechSpain· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Abanza Tecnomed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Abanza Tecnomed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue